HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Rotavirus vaccination: a priority for high-risk children].

Abstract
Rotaviruses cause acute gastroenteritis; mostly in young children. Infant rotavirus vaccines have been licensed in Europe and provide excellent protection against severe gastroenteritis, but are not widely implemented due to the perceived benign character of rotavirus disease and unfavourable cost-effectiveness. Rotavirus vaccines are currently unavailable in the Netherlands which leaves a particularly vulnerable group of infants--those with prematurity, low birth weight or severe congenital malformations--at increased risk of rotavirus disease, complications and even death. Rotavirus vaccination should be made available to these infants, but due to the strict age limits for the rotavirus vaccination (which must be started at < 14 weeks), vaccination cannot be adequately organised within the Dutch National Immunisation Programme (NIP) which relies on well-baby clinic visits. Organising rotavirus vaccination for high-risk infants through paediatric secondary care could overcome this problem and be implemented independent of decisions on uptake of rotavirus vaccination within the Dutch NIP.
AuthorsPatricia C J L Bruijning-Verhagen, Marc J M Bonten
JournalNederlands tijdschrift voor geneeskunde (Ned Tijdschr Geneeskd) Vol. 157 Issue 37 Pg. A6673 ( 2013) ISSN: 1876-8784 [Electronic] Netherlands
Vernacular TitleRotavirusvaccinatie: prioriteit voor hoog-risicokinderen.
PMID24020626 (Publication Type: Journal Article)
Chemical References
  • Rotavirus Vaccines
Topics
  • Female
  • Gastroenteritis (prevention & control, virology)
  • Humans
  • Immunization Programs (methods)
  • Infant
  • Infant, Newborn
  • Male
  • Netherlands
  • Rotavirus (immunology)
  • Rotavirus Infections (prevention & control)
  • Rotavirus Vaccines (administration & dosage, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: